ARMC5変異によるBMAD家族例の長期内科的治療に関する報告がFront Endocrinolに発表されました

Arai M, Ono M, Inoue R, Tajima K, Aomori K, Tatenuma T, Suzuki S, Yamanaka S, Fujii S, Terauchi Y, *Shirakawa J. Case Report: A family presenting with β-adrenergic/vasopressin-responsive bilateral macronodular adrenal disease with an ARMC5 mutation treated with metyrapone monotherapy for more than 5 years. Front Endocrinol. in press, 2026.（*責任著者：白川純）